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Abstract 
To date, medicinal plants are the most important resources in the discovery of new drugs. Clinacanthus 
nutans has been used traditionally in Thailand folk medicine to promote overall well-being. A few 
biological constituents of C. nutans and their physiological functions have been evaluated in previous 
studies. However, the mechanisms of action, potency and efficacy of the plant are still not well 
understood. In this review, the pharmacological properties of C. nutans such as anti-inflammatory 
effects, anti-proliferation, anti-venom and anti-bacterial activities, and their underlying mechanisms of 
action are presented and discussed.   
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Complementary and alternative medicine (CAM) 
is becoming popular nowadays. It encompasses 
a wide range of practices, knowledge and 
treatments which are not related to modern 
medical profession. These include massage 
therapy, acupuncture, chiropractic and herbal 
foods [1-6]. Countries in which CAM is widely 
used include Southeast Asia, United States, 
United Kingdom and Australia [7]. Studies 
indicate that CAM is mostly used in treatment 
and management of chronic diseases but less 
used in depressive disorders [3]. It has some 
advantages over conventional medicines. For 
example, herbal products are cheaper than 
conventional treatments [8,9]. Although the use 
of CAM is popular amongst patients, there is lack 
of scientific evidence on its clinical effectiveness. 
In addition, safety issues related to CAM remain 
of concern to scientists and health care providers 
[9,10]. 
 
Clinacanthus nutans is a medicinal plant and a 
member of the family Acanthaceae. The plant is 
popular in many tropical countries such as 
Thailand, Malaysia and Indonesia due to its 
ready availability and medicinal properties. The 
plant has different names based on the native 
languages of the countries. In Thailand, C. 
nutans is recognized as Phaya Yo or Phaya 
Plong Thong whereas it is named Belalai Gajah 
or Sabah Snake Grass in Malaysia. It is a short 
shrub with hairy branches and small oblong 
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leaves. Six to seven pairs of side veins are found 
under the leaves while white internodes and 
vertical strips are distributed throughout the 
stem. The branches are topped with dull red-
coloured flowers with green base and yellow 
streaks on the lower lips [11-15].  
 
In Thailand, C. nutans leaves are traditionally 
used for treating skin diseases and bites from 
snakes and insects [13,16]. A topical cream 
containing ethanolic extract of C. nutans leaves 
has been used in the treatment of viral infections 
such as herpes genitalis, varicella-zoster and 
herpes simplex [16-19]. Moreover, C. nutans is 
used as an anti-inflammatory agent to relieve 
swelling [12,20,21]. A cross-sectional study in 
Malaysia has discovered that C. nutans is able to 
act as an anti-diabetic agent [22]. Due to the 
pharmaceutical properties of C. nutans, the Thai 
Ministry of Public Health has shortlisted it as one 
of the medicinal plants for public healthcare [23]. 
Moreover, a survey of ethnobotanical 
applications of medicinal plants showed that C. 
nutans ranks amongst the top 5 commonly used 
plants in Singapore [24]. Previous studies have 
shown the presence of stigmasterol, β-sitosterol, 
lupeol, myricyl alcohol, botulin, sulphur-
containing glycosides and glycoglycero-lipids in 
C. nutans [16,25-29]. In addition, six C-glycosyl 
flavones have been isolated and characterised 
from the leaves and stem of C. nutans, while 
chlorophyll derivatives (phaeophytins) were 
isolated from the leaves [13,15]. Some 
cerebrosides and glycerol derivatives have also 
been isolated from the leaves of C. nutans [16]. 
Reports from previous studies suggest that C. 
nutans is safe for consumption. Ames test 
revealed no evidence of mutagenic or 
carcinogenic effects after exposure to aqueous 
extract of C. nutans leaves [30]. No mortality or 
morbidity was found in animals following single 
and repeated dose administrations of the plant 
extract [30]. Furthermore, studies on the toxic 
effect of C. nutans on human gingival fibroblasts 
showed that the cells survived well after 
exposure to the plant extract [31].  In this review, 
the medicinal properties of C. nutans and its 
mechanism of action are discussed. 
 
CHEMICAL CONSTITUENTS OF C. NUTANS 
 
Recently, Chelyn et al conducted a study on the 
flavone C-glycoside content of the leaves of C. 
nutans from different geographical locations in 
Malaysia [13]. Preliminary thin layer 
chromatography screening of the samples 
demonstrated two distinguishable green and 
yellow fluorescent bands. Flavone C-glycosides 
with apigenin backbone were found in the green 
color band, comprising shaftoside, isovitexin and 
vitexin. On the other hand, the yellow color band 
was identified as flavone C-glycosides containing 
luteolin backbone, consisting of isoorientin and 
orientin.  Among all the compounds identified, 
only shaftoside was present in all the samples 
tested, regardless of geographical location from 
where the samples were collected. The other 
compounds were present in samples from 
specific geographical regions. This might be due 
to differences in climate and soil, and differences 
in stages of maturity of the plants harvested. 
Sample handling processes such as drying 
temperature and methods, as well as storage 
conditions might also affect the composition of 
the flavonoids. Since shaftoside is the only stable 
flavonoid in all samples, it has been suggested 
for use as a chemical marker for C. nutans raw 
material [13]. In another study, Sakdarat et al 
reported the presence of chlorophyll derivatives 
in chloroform extract of leaves of C. nutans [15]. 
In that study, compound 1, a dark green 
amorphous solid was identified as 132-hydroxy-
(132-S)-phaeophytin-b through proton (1H) and 
carbon-13 (13C) nuclear magnetic resonance 
(NMR). Compound 2, which appeared as a green 
powder, displayed signals corresponding to 
amine, ester and hydroxyl functional groups in 
the infrared (IR) spectrum, indicating that it is a 
132-hydroxy-(132-S)-phaeophytin-a. Compound 
3, identified as 132-hydroxy-(132-R)-phaeophytin 
a by IR, 1H NMR and 13C NMR, was closely 
equivalent to compound 2. Results from antiviral 
tests showed that these compounds inhibited 
HSV activity [15].  
 
Chromatographic purification of ethanol extract of 
C. nutans showed that cerebrosides appeared as 
a colorless solids while monoacylmonogalac-
tosylglycerol was in pale yellow color. The 
cerebrosides had a glycosphingolipid structure, 
with sugar moieties, amide function and long 
chain aliphatic and olefinic groups. Methanolysis 
of the sample yielded methyl glucoside, 
trihydroxy long-chain base and fatty acid methyl 
esters, which further confirmed the presence of 
cerebrosides. Sugar and glycerol moieties were 
present in the monoacylmonogalactosylglycerol. 
The sugar was a β-D-galactopyranose while the 
long chain fatty acid was linolenic acid. These 
compounds did not exhibit anti-HSV and anti-
inflammatory activities [16]. The chemical 
constituents of ethanolic extract of the aerial 
parts of C. nutans and their bioactivities have 
been reported [32]. Four new clinamides and 2-
cis-entadamine-A showed antiviral activities 
against dengue virus, as well as anti-
inflammatory and immune-protective activities.  
 
Based on the structure of the active constituents 
of C. nutans, Janwitayanuchit et al synthesized 
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some 1,2-O-diacyl-3-O-β-glycopyranosyl-rac-
glycerols in order to investigate the 
stereochemical influence of C-2 in the glycerol 
backbone on anti-HSV property [33]. It was 
shown that the presence of olefinic fatty acyl 
moieties produced higher inhibitory effects 
against HSV-1 and HSV-2. However, the sugar 
moiety (glucose or galactose) and 
stereochemistry at C-2 had no significant effect 
on anti-viral activity.  
 
A novel polysaccharide-peptide compound has 
been isolated from C. nutans extract. The 
complex comprised about 87.25 % carbohydrate 
and 9.37 % protein. Further analysis revealed 
that the complex was composed of D-glucose, L-
arabinose, D-mannose, D-galactose and L-
rhamnose [34]. The phytochemical composition 
of the plant changes as a function of age. The 
levels of total flavonoids and total phenolic 
compounds were highest in 6-month-old buds 
[35]. The flavonoids isolated in that study 
included catechin, quercetin, kaempferol, 
luteolin, as well as phenolic acid, caffeic acid and 
gallic acid [35]. 
 
MEDICINAL PROPERTIES OF C. NUTANS 
 
Anti-viral properties  
 
Herpes simplex virus (HSV) is classified into two 
antigenic types: HSV-1 and HSV-2. Both viruses 
contain linear and double-stranded DNA 
molecules with approximately 150 kbp. Infection 
with HSV-1 causes cold sores, encephalitis, 
corneal damage, blindness and herpetic whitlow; 
whereas genital herpes which is a common 
sexually transmitted disease is mainly caused by 
HSV-2 [36]. Currently, there are various types of 
antiviral drugs available in the market for the 
management of HSV infections, the most 
commonly used of which is AcyclovirTM (ACV). 
However, studies have shown that the presence 
of mutated or resistant strains of HSV affects the 
efficacy of ACV [37]. Hence, CAM can be 
explored as a potential treatment for HSV 
infections.  
 
In Thai folk medicine, C. nutans is commonly 
applied onto viral lesions or rashes on the skin. It 
has been demonstrated that the size of virus 
plaque became smaller after incubation with C. 
nutans extract, suggesting that C. nutans extract 
could affect the intracellular activity of HSV-2 
[20]. Some bioactive constituents of C. nutans 
such as polyphenolics, glycosides and terpenes 
have been identified as promising anti-HSV 
agents [12, 16]. The anti-HSV activity was further 
evident after it was shown that C. nutans leaf 
extracts produced anti-HSV-1 and HSV-2 
properties [12]. The plaque reduction assay 
revealed that n-hexane extract of C. nutans had 
a stronger anti-HSV-1 activity than 
dichloromethane extract or methanol extract. On 
the other hand, the three extracts produced only 
slight anti-HSV-2 activities. These findings 
demonstrate the potential of C. nutans as an 
antiviral agent. 
 
In another study, Sakdarat et al tested the anti-
viral activities of three active compounds isolated 
from C. nutans [15]. Inhibition of HSV was 
exhibited with 132-OH-(132-S)-phaeophytin, 132-
OH-(132-R)-phaeophytin-a and 132-OH-(132-S)-
phaeophytin-a at concentrations of 1.96, 3.11 
and 3.11 µM, respectively. In the pre-viral entry 
stage, 100% inhibition of viral activity was 
produced by all the tested compounds. However, 
at the post-viral entry stage, viral activity was 
inhibited by 30 %. Thus, the three compounds 
inhibited HSV-1 infection before the virus entered 
the host cell. These findings indicate that the 
compounds might be acting through interference 
with the viral envelope structure that is required 
for adsorption and entry of the virus into the host 
cells. Extracts of C. nutans might also have a 
direct inactivation action on the virus, thereby 
inhibiting its activity [20]. 
 
Clinical trials have been carried out to evaluate 
the antiviral efficacy of C. nutans extracts. A 
meta-analysis revealed that the use of C. nutans 
cream against herpes genitalis caused by HSV-2 
demonstrated full recovery and 100 % crusting 
relative to placebo [19]. In addition, combination 
of C. nutans extract and ACV produced 
synergistic antiviral results [15,19]. In another 
study, a randomized, placebo-controlled trial 
demonstrated that when used topically, C. 
nutans extract improved healing of VZV lesions 
and reduced pain scores more rapidly in the 
treated group [38]. A cream formulated with C. 
nutans was also found to be effective in the 
treatment of herpes zoster, in another study [39]. 
Although C. nutans extract was effective in the 
treatment of VZV infection, its mode of action still 
remains unclear. Hence, further studies should 
be conducted to elucidate its mechanism of 
action. C. nutans extract has also been shown to 
be protective against human papillomavirus 
infection through prevention of viral particle 
binding to the cell receptor [40,41]. In addition, 
ethanolic extract of the aerial parts of C. nutans 
has been shown to be moderately effective 
against the dengue virus at a concentration of 
31.04μg/mL [32,42]. 
 
Anti-inflammatory activity  
 
Inflammation  is   an  immune  response   which  
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eliminates pathogens such as microbes from the 
body. It is a protective mechanism which helps to 
get rid of infections and injuries via migration of 
leukocytes and proteins from circulation to the 
infected or damage sites. Consequently, this 
defence involves polymorphonuclear neutrophils, 
especially with respect to acute and chronic 
inflammations. Thus, dysregulation of neutrophil 
functions leads to the production of pro-
inflammatory mediators, toxic reactive oxygen 
species and release of myeloperoxidase (MPO) 
and elastase, resulting in inflammation-induced 
tissue lesions [43,44].  
 
The anti-inflammatory effect of C. nutans leaf 
extract on neutrophils has been demonstrated 
using ear and paw edema rat models [21]. In 
addition, inhibition of neutrophil marker enzyme, 
MPO activity was found to be associated with 
reduced neutrophil migration. Furthermore, C. 
nutans exerted concentration-dependent 
inhibitory effects on chemotaxis and 
chemokinesis of neutrophils. This in turn 
attenuated superoxide anion generation as well 
as the release of MPO and elastase.   The anti-
inflammatory effect of C. nutans was further 
tested on recurrent aphthous stomatitis [45]. In a 
clinical evaluation, patients were instructed to 
apply the C. nutans in orabase to the lesion 4 
times daily. Results obtained showed that C. 
nutans treatment shortened the healing time 
when compared to placebo, although the 
duration of pain was not affected [45]. In a 
docking study, some active phytochemical 
constituents of C. nutans were shown to bind to 
human neutrophil elastase enzymes involved in 
inflammation [46]. These compounds included β-
sitosterol, clinacoside A-C, cycloclinacoside A1, 
lupeol, shaftoside, vitexin, isovitexin, as well as 
orientin and isoorientin. Isovitexin and isoorientin 
showed preference for HNE, nitric oxide 
synthase, squalene synthase, xanthine oxidase, 
HNE, and matrix metalloproteinases II and III. On 
the other hand, clinacoside B produced the 
lowest binding energy for all the candidate 
enzymes except xanthine oxidase and squalene 
synthase, while orientin and vitexin docked and 
bound to nitric oxide synthase and HNE only. All 
the compounds were predicted to have inhibitory 
potential against cytochrome P4502D6, with the 
exception of isoorietin and orientin. 
 
Mai et al elucidated the mechanism involved in 
the anti-inflammatory property of C. nutans 
through the application of lipopolysaccharide 
(LPS)-treated RAW264.7 macrophages and 
human embryonic kidney cells transfected with 
Toll-like receptor-4 (TLR-4) [47]. Extracts of C. 
nutans reduced the expression of nitric oxide 
(NO) and cytokines, and also inhibited the 
expression of LPS-triggered TLR-4 inflammatory 
proteins like ERK, p65, p38, c-Jun N-terminal 




Chemotherapy drugs and radiotherapy may 
induce oxidative stress resulting in cell damage. 
These are unwanted side effects of cancer 
therapy which may be reduced by compounds 
with antioxidant properties. C. nutans extracts 
are potential cytoprotective antioxidant agents. In 
a comparative study of antioxidant properties of 
various solvent extracts of C. nutans, higher 
DPPH and galvinoxyl radical scavenging 
activities were obtained with CHCl3 when 
compared with methanol and aqueous extracts, 
while the aqueous extract exhibited the highest 
NO radical scavenging activity [14]. A 
comparative study of DPPH radical scavenging 
activity between young and old buds of C. nutans 
revealed that buds aged 12 months were more 
active than 6 month-old, with IC50 values of 64.6 
and 73.5 µg/mL, respectively [35]. However, the 
younger buds had higher activity in FRAP assay. 
In another comparative in vitro study, ethyl 
acetate and ethanol extracts of C. nutans were 
shown to have higher DPPH radical scavenging, 
oxygen radical absorbing and ß-carotene 
bleaching potential than extracts from 




Chloroform extract of C. nutans has been shown 
to be capable of inhibiting the proliferation of 
some human cancer cells, when compared to the 
aqueous and methanol extracts which exerted 
relatively weak inhibitory effects [14]. 
Interestingly, the cytotoxic effect and percentage 
of inhibition were significantly lower in endothelial 
cells exposed to the three extracts [14]. The 
bioactive component of C. nutans, CNP-1-2 
inhibited the growth of human gastric cancer 
cells SGC-7901 [34].  Similarly, it has been 
demonstrated that extracts of 6-month-old C. 
nutans buds exhibited significant anticancer 
activity against HeLa cancer cells [35]. In 
addition, C. nutans extracts have produced anti-
carcinogenic effects against MCF-7 cells [48]. 
These results show that the extracts of C. nutans 
exert cancer-inhibitory properties, thereby 
supporting their use in cancer treatment. 
 
Huang et al showed that C. nutants ethanolic 
extract exhibited potent tumoricidal effect in 
tumour-bearing mice [49]. ICR mice injected with 
HepA hepatocarcinoma tumour cells received C. 
nutans treatment (3 and 10 mg/kg) for 10 days, 
resulting in significant reduction in tumour size, 
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when compared to the untreated group. The 
hepatoma cells were in apoptotic state after the 
treatment. This was confirmed by increased Bax 
and Caspase-3 protein expressions in the cells. 
Furthermore, the hepatoma cells showed 
reduced proliferation with de-activation of Akt 
protein.  Although C. nutans extracts inhibit 
various types of cancer, studies have shown that 
they are not toxic to hypoxic human Saos-2 
osteosarcoma cells, which are known to be 




Acne develops when bacteria such as 
Propionibacterium acnes and Staphylococcus 
epidermis multiply. Propionibacterium acnes is a 
common skin anaerobe behind or in the 
inspissated sebum. Scientists believe that P. 
acnes could produce certain organic acids that 
trigger the inflammatory response in acne [43]. 
Chomnawang et al incubated the two microbial 
strains with C. nutans extract and found that the 
growth of the bacteria was not significantly 
inhibited [51]. Similar results were obtained by 
Yang et al., who however reported that the 
extract inhibited the growth of Staphylococcus 





C. nutans is a popular anti-snake venom in 
Thailand and Malaysia. However, it has been 
reported that aqueous extract of C. nutans had 
no inhibitory effect on Naja siamensis bite-
induced neuromuscular transmission failure [53]. 
In another study, it was shown that extracts of C. 
nutans might prevent fibroblast cell lysis caused 
by Heterometrus laoticus scorpion venom [54], 
thus supporting the use of C. nutans as an 




C. nutans extract was found to enhance 
lymphocyte proliferation at the concentration 
range of 0.5 - 5 µg/mL [55]. However, it reduced 
the proliferation of lymphocyte at the 
concentration range of 1 - 5 mg/mL. At the higher 
concentration range of C. nutans extract, the 
activity of natural killer cells was significantly 
decreased while the level of IL-4 was enhanced. 
These results suggest the modulation of 
nonspecific cell-mediated immune responses, 
which might be useful in treating some viral 
infections. 
 
Modulation of neurotransmission 
 
Methanol extract of C. nutans leaves fed to 
Balb/c mice for 14 days activated 
acetylcholinesterase (AChE) and modulated 
cholinergic neurotransmission in mice kidney, 




Abdul Rahim et al showed that oral 
administration of methanol extract of C. nutans 
exerted both central and peripheral 
antinociceptive activities via activation of opioid 
receptors and modulation of L-arginine/NO-




Studies have shown that C. nutans extract 
selectively inhibited histone deacetylase (HDAC)-
1 and HDAC-6 expressions in neuronal cells, and 
also protected endothelial cells and astrocytes 
from hypoxic-induced cell death [58]. In addition, 
the C. nutans extract prevented neuronal cell 





It has been demonstrated that water and 
methanolic extracts of C. nutan leaf lowered 
insulin, serum retinol binding protein-4 and 
fasting blood glucose in high fat and high 
cholesterol (HFHC)-fed rats [59]. Results 
obtained from studies of insulin resistance using 
homeostatic model showed that both extracts 
significantly improved insulin sensitivity in the 
HFHC-fed rats. The anti-hyperlipidemic effect of 
C. nutans was mediated through up-regulation of 
genes coding for phosphatidylinositol-3-
phosphate, insulin receptor substrate, 
adiponectin receptor and leptin receptor [59]. The 
efficacies of aqueous and methanolic leaf 
extracts of C. nutan in attenuating oxidative 
stress were further tested in hyperlipidemia-
induced rats [60]. The results indicated that both 
extracts increased the activities of serum 
antioxidant enzymes and upregulated hepatic 




Clinacanthus nutans is used as famous medicine 
among folklore healers in many countries. 
However, there is lack of scientific evidence on 
the effectiveness of this medical plant. Hence, a 
better understanding regarding the mechanisms 
of action of C. nutans is required. This will 
ultimately unveil the potential of C. nutans in the 
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treatment various diseases, and help in 
improving quality of life of patients. Although the 
role of C. nutans and its biological constituents 
have been widely documented in both in vivo and 
in vitro studies, the number of clinical trials 
carried out is limited. For example, the effect of 
C. nutans on skin rashes could be tested to 
further support the therapeutic efficiency of the 
plant. Furthermore, the possibility of C. nutans 
extracts being made into commercially available 




Studies on the anti-viral, anti-inflammation, 
antioxidant, anti-cancer and anti-venom 
properties of C. nutans were reviewed in this 
paper. The progress of work in vitro and animal 
studies provides evidence that C. nutans could 
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